Rating History for Medpace (MEDP) by Barclays
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 3/6/2026 | Luke Sergott | Upgrade | Equalweight (Underweight) |
500.00 (N/A) |
469.38 (470.59) |
0.26% | Details |
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 3/6/2026 | Luke Sergott | Upgrade | Equalweight (Underweight) |
500.00 (N/A) |
469.38 (470.59) |
0.26% | Details |
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||